Bob Nance Email & Phone Number

Lansdale, Pa, Us

Clinton, New Jersey

Bob is an experienced sales and marketing executive and consultant in marketing, strategic planning and strategic transactions. He has experience in pharmaceuticals, diagnostics and consumer products, and has a demonstrated record of success at every level. Has served in various management and executive positions in sales, marketing, and strategic planning for healthcare companies including The Upjohn Company, Beckman Instruments and American Diagnostics Corporation. Has also been founder and/or a part of several start-up companies. As a contract consultant, he has provided services to companies in the pharmaceutical, biotechnology, diagnostics, and consumer products industries, developing specialized marketing and promotional programs, as well as conducting market research/intelligence projects, strategic assessments and assisting in strategic transactionsWith The Sage Group, Bob conducts analyses of acquisition and alliance opportunities and co-manages alliance and acquisition transactions.The Sage Group provides high value, senior level strategic management and transactional services to the biotechnology, pharmaceutical, medical devices and diagnostic products industries.Bob is a strong leader and team builder with excellent communication, presentation and organizational skills;

Aedan Pharmaceuticals, L.L.C. is a specialty pharmaceutical and consumer products company founded to bring products to market based on patented and proprietary drug delivery technologies and targeted at niche markets including the 40% of adults who have difficulty swallowing tablets and capsules (Harris Interactive). Our technologies have immediate application in selected consumer products and in over-the-counter (OTC) drugs. Our technology has the potential to significantly improve medicines and supplements for children and companion animals.Aedan intends to deliver improvements to prescription drugs too; especially for those conditions requiring urgent dosing such as epilepsy and migraine headache and for drugs and supplements used for patients in long term care and those requiring enteral feeding. To expedite the process Aedan modifies and re-formulates existing drugs to suit these market niches. Aedan believes that it is critical to get products to the market “quickly” and not to become mired in revisiting the R&D process.